SOPHIA GENETICS SA
SOPH·H82027105·US·Common Stock·Healthcare - Health Information Services-13D/G
SOPH (SOPHIA GENETICS SA) is held by 40 institutional investors as of Q2 2026. Largest holders: GENERATION INVESTMENT MANAGEMENT LLP ($39.2M), AKRE CAPITAL MANAGEMENT LLC ($21.5M), ROYCE & ASSOCIATES LP ($19.5M). Net institutional sentiment: Bullish.
40
Holders
(2 Elite)
$138.8M
Total Value
70% (37)
Consensus
26 buying - 11 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Oct 7, 2026 · Activists Feb 11, 2026 · Congress none
InsiderPKPuylaert KevinSell $1KOct 5, 2026
InsiderXZXu ZhenyuSell $60KOct 5, 2026
InsiderVDVan Well DaanSell $50KOct 5, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 44
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer